Evaluation of Bactiguard Antegrade Femoral Nails for treating femur fractures
Official title: Post-Market Clinical Follow-up Study on the ZNN™ Bactiguard ® Antegrade Femoral Nails (Implants and Instrumentation). A Multicenter, Prospective, Consecutive Series
Run by Zimmer Biomet · NCT05339360 · Data updated 2026-11-12
This study is testing a new type of nail used in surgery to fix femur fractures to see how safe and effective it is for helping patients heal.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Zimmer Biomet Industry-sponsored |
| Locations | 2 sites (Santa Cruz de Tenerife, Santa Cruz de Tenerife and 1 other locations) |
| Status | Recruiting |
| Started | January 16, 2024 |
| Main results expected | January 2027 |
| Study ends | December 2027 |
| Registry record updated | November 25, 2025 |
| Trial ID | NCT05339360 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with femoral fractures or osteotomies requiring surgical intervention eligible for fixation with intramedullary nails.
✕Probably not a fit
Patients who are skeletally immature or have significant bone quality issues or previous obstructions in the medullary canal may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, prospective study focuses on the ZNN Bactiguard Antegrade Femoral Nails, which are used for the internal fixation and stabilization of femoral fractures and osteotomies. The study aims to collect data on the safety, performance, and clinical benefits of this CE-marked device, already available on the market. Key endpoints include assessing fracture healing through radiological and clinical evaluations, as well as monitoring safety and post-operative complications. Data will be collected at multiple time points over a year to ensure comprehensive follow-up.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of the effectiveness and safety of the Bactiguard system in treating femoral fractures.
How similar studies have gone: While this study builds on existing knowledge of intramedullary nails, it specifically evaluates a novel device with a focus on post-market surveillance, making it a unique contribution to the field.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient must be 18 or older * Patient must have a signed EC-approved informed consent. * Patient must have a femoral fracture (open, closed, monolateral, or bilateral) requiring surgical intervention or osteotomy and be eligible for fixation by intramedullary nailing. Patients with delayed treatment (initial treatment by external fixation due to swelling/ high energy trauma followed by definitive treatment by intramedullary nail) can also be included. * Patient has been or is scheduled to be treated with the ZNN Bactiguard System Antegrade Femoral Nail * Patient must be able and willing to complete the protocol required for follow-up * Patients capable of understanding the surgeon's explanations and following his instructions Exclusion Criteria: Skeletally immature patients * Medullary canal obliterated by a previous fracture or tumor * Bone shaft having excessive bow or a deformity * Lack of bone substance or bone quality, which makes stable seating of the implant impossible * All concomitant diseases that can impair the operation, functioning or the success of the implant * Insufficient blood circulation * Infection * Patient is unwilling to give consent. * Patient is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, subjects with alcohol/drug addiction, known to be pregnant or breast feeding) * Patient anticipated to be non-compliant and/or likely to have problems with maintaining follow-up program (e.g. patient with no fixed address, long-distance, plans to move during the course of study) * Patients not expected to survive the duration of the follow-up program
Where it's running
-
Manchester Royal Infirmary
Manchester, Manchester, United Kingdom Recruiting -
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, Santa Cruz de Tenerife, Spain Active not recruiting
Study contacts
- Study coordinator: Gemma de Ramon Francàs
- Email: gemma.deramonfrancas@zimmerbiomet.com
- Phone: +41 79 377 11 96
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Robot-assisted closed reduction for femoral shaft fractures
This study tests whether robot-assisted closed reduction leads to better fracture alignment and recovery than conventional reduction in adults with unilateral, acute femoral shaft fractures.
-
Comparing two types of nerve blocks for pain relief in femur fracture surgery
This study is testing which of two types of nerve blocks can provide better pain relief for patients having surgery for femur fractures.
-
Comparing Remimazolam and Propofol for Delirium After Surgery
This study is testing whether remimazolam or propofol is better at preventing confusion after surgery in older patients getting hip or knee replacements.
-
Curved-walking training to help stroke, Parkinson’s, and femur fracture recovery
This study tests curved-walking training to see if it helps people recovering from stroke, Parkinson’s disease, or recent femur fracture.
-
Carbon‑fiber lateral plate versus plate-and-nail repair for distal femur fractures
This trial will see if a carbon-fiber (CarboFix) lateral femur plate leads to fewer non-unions than the standard plate-plus-nail repair in adults having surgery for a distal femur fracture.
-
Comparing knee joint replacement to surgical fixation for elderly patients with distal femur fractures
This study is testing whether total knee joint replacement or surgical fixation works better for older patients with broken thigh bones near their knee to help them feel less pain and improve their daily activities.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.